Copyright 2016 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use.
To the Editor A recent Invited Commentary by Kim1 on the article titled “Analysis of Inner and Outer Retinal Thickness in Patients Using Hydroxychloroquine Prior to Development of Retinopathy”2 pointed out current knowledge about the varying sensitivity of tests used to screen for hydroxychloroquine retinopathy. However, it was written in a small window of time between publication of the articles that have amplified knowledge of this disease and adoption of this knowledge into a new set of American Academy of Ophthalmology screening recommendations, which have just been published.3 This 2016 revision modifies key points from the previous 2011 guidelines.4 We urge readers to consult this new document, and herein we summarize the most critical changes in recommended practice.
Kim JE, Marmor MF. Update on Screening Recommendations for Hydroxychloroquine Retinopathy. JAMA Ophthalmol. 2016;134(7):849. doi:10.1001/jamaophthalmol.2016.1252
Customize your JAMA Network experience by selecting one or more topics from the list below.